Table 4.

Summary of Results of PEG Combined With SSAs Meta-Analysis on Glucose Metabolism Outcomes

Main AnalysisNo. of PatientsMean Difference (95% CI)P ValueI2 (%)References
FPG (mmol/L)89−0.09 (−0.58 to 0.40)0.72193.5(17, 32–34)
HbA1c (%)103−0.12 (−0.24 to 0.00)0.05292.2(17, 28, 32, 34)
FPI (mU/L)89−3.63 (−4.11 to −3.14)0.0000(17, 32–34)
HOMA-I77−0.98 (−2.33 to 0.37)0.15460.5(17, 32, 34)
HOMA-β (%)77−29.99 (−67.67 to 7.68)0.11988.2(17, 32, 34)
Main AnalysisNo. of PatientsMean Difference (95% CI)P ValueI2 (%)References
FPG (mmol/L)89−0.09 (−0.58 to 0.40)0.72193.5(17, 32–34)
HbA1c (%)103−0.12 (−0.24 to 0.00)0.05292.2(17, 28, 32, 34)
FPI (mU/L)89−3.63 (−4.11 to −3.14)0.0000(17, 32–34)
HOMA-I77−0.98 (−2.33 to 0.37)0.15460.5(17, 32, 34)
HOMA-β (%)77−29.99 (−67.67 to 7.68)0.11988.2(17, 32, 34)
Table 4.

Summary of Results of PEG Combined With SSAs Meta-Analysis on Glucose Metabolism Outcomes

Main AnalysisNo. of PatientsMean Difference (95% CI)P ValueI2 (%)References
FPG (mmol/L)89−0.09 (−0.58 to 0.40)0.72193.5(17, 32–34)
HbA1c (%)103−0.12 (−0.24 to 0.00)0.05292.2(17, 28, 32, 34)
FPI (mU/L)89−3.63 (−4.11 to −3.14)0.0000(17, 32–34)
HOMA-I77−0.98 (−2.33 to 0.37)0.15460.5(17, 32, 34)
HOMA-β (%)77−29.99 (−67.67 to 7.68)0.11988.2(17, 32, 34)
Main AnalysisNo. of PatientsMean Difference (95% CI)P ValueI2 (%)References
FPG (mmol/L)89−0.09 (−0.58 to 0.40)0.72193.5(17, 32–34)
HbA1c (%)103−0.12 (−0.24 to 0.00)0.05292.2(17, 28, 32, 34)
FPI (mU/L)89−3.63 (−4.11 to −3.14)0.0000(17, 32–34)
HOMA-I77−0.98 (−2.33 to 0.37)0.15460.5(17, 32, 34)
HOMA-β (%)77−29.99 (−67.67 to 7.68)0.11988.2(17, 32, 34)
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close